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Autaptic cultures of human induced 
neurons as a versatile platform for 
studying synaptic function and 
neuronal morphology
pascal Fenske  1,2, M. Katharina Grauel  1,2, Marisa M. Brockmann  1,2, Anja L. Dorrn  1,2, 
thorsten trimbuch1,2 & Christian Rosenmund  1,2,3
Recently developed technology to differentiate induced pluripotent stem cells (iPSCs) into human 
induced neurons (iNs) provides an exciting opportunity to study the function of human neurons. 
However, functional characterisations of iNs have been hampered by the reliance on mass culturing 
protocols which do not allow assessment of synaptic release characteristics and neuronal morphology 
at the individual cell level with quantitative precision. Here, we have developed for the first time 
a protocol to generate autaptic cultures of iPSC-derived iNs. We show that our method efficiently 
generates mature, autaptic iNs with robust spontaneous and action potential-driven synaptic 
transmission. The synaptic responses are sensitive to modulation by metabotropic receptor agonists 
as well as potentiation by acute phorbol ester application. Finally, we demonstrate loss of evoked 
and spontaneous release by Unc13A knockdown. This culture system provides a versatile platform 
allowing for quantitative and integrative assessment of morphophysiological and molecular parameters 
underlying human synaptic transmission.
Recent technological advances provide access to human neurons through induction of iPSCs1–5 or direct con-
version of fibroblasts into neurons6,7. This enables researchers to model human neurological diseases using 
patient-derived neurons or to study protein function in human neurons with a controlled genetic background8,9. 
So far, all studies investigating evoked neurotransmitter (NT) release in human induced neurons (hiNs) have 
been performed in mass culture3,5,8–10. However, their depth of analysis of synaptic properties and parameters 
was limited due to the network formed in this conventional culture system. Most studies therefore analysed only 
passive membrane properties, action potential (AP) generation and spontaneous activity within the network. 
Additionally, in some studies synaptic responses were evoked by extracellular or optogenetic stimulation of pre-
synaptic neurons, but none of these techniques give a quantitative measure of the synaptic input and output of 
individual neurons or synaptic parameters, such as the vesicular release probability (PVR).
Autaptic cultures, in which single neurons grow in isolation on astrocytic microislands and form synapses 
exclusively with themselves11, provide an experimental system that allows the quantitative assessment of input 
and output properties of individual neurons, both in morphological and in functional experiments12. In addition, 
parameters such as vesicle fusogenicity, PVR, short-term plasticity and synaptic vesicle (SV) pool sizes can be 
assessed13,14. The autaptic culture system has proven particularly valuable in the analysis of presynaptic release 
mechanisms in rodent neurons, including docking/priming and the functionality of the fusion machinery15–23 
and developmental phenotypes12. However, utilizing the standard protocol of murine autaptic neurons in our 
hands (Data not shown) as well as in others24 limited the accessibility of hiN autaptic cultures to experimental 
assessments, due to their long differentiation time and the poor survival rate of solitary hiNs.
Here, we report the first reliable method for autaptic cultures of hiNs. The two-phase protocol yielded single 
hiNs that reliably survived and matured to form fully functional synapses. The autaptic iNs displayed robust spon-
taneous and evoked NT release, which was modulated by metabotropic receptor agonists and potentiated by acute 
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phorbol ester application. Finally, we demonstrated that this preparation is suitable for molecular interference as 
knocking down Unc13A using a shRNA-based approach was sufficient to abolish both spontaneous and evoked 
NT release. Taken together, the autaptic culture system for hiNs can serve as a reliable platform for studying 
human synaptic proteins and testing the genetics of human neuronal function.
Results
Establishment of an autaptic culturing protocol for hiNs. In initial experiments, we differentiated 
iPSCs into hiNs using the protocol described by Zhang and colleagues5 and plated the hiNs onto mouse-derived 
astrocytic microislands on day 4 post induction (DPI). We noticed that this approach resulted in low survival 
rates after 6 weeks in culture, with only a small fraction of hiNs suitable for electrophysiological assessment. These 
observations led us to hypothesize that hiNs require a period of significant cell-to-cell contact with other neurons 
in order to mature.
We therefore adapted the differentiation protocol by splitting it into two phases: in the first phase we induced 
hiNs from iPSCs by forced expression of Ngn2 as described (Zhang et al., 2013) and allowed them to develop as 
mass culture. In the second phase we carefully dissociated the iNs and reseeded them onto astrocytic microis-
lands (Fig. 1A,C). Despite the fact that hiNs grew extensive neurites during the mass-culture phase, we were able 
to efficiently dissociate them for replating. Replated iNs were subsequently cultured for 14–21 days before they 
were further analysed. Interestingly, the survival rate of iNs after replating was surprisingly high, only requiring 
a seeding density of 555 iNs/cm2 compared to 333 neurons/cm2 for murine hippocampal neurons derived from 
newborn animals12.
In order to find the optimal time point for replating the hiNs, we performed a timeline experiment, in which 
we replated hiNs at DPI 14, 35 and 60. We then used whole-cell patch-clamp recordings in order to examine the 
passive and active membrane properties of the autaptic hiNs after 14 to 21 days in autaptic culture (Fig. 1B). All 
autaptic iNs possessed voltage-dependent sodium and potassium currents and demonstrated robust AP firing 
as a function of injected current, regardless of the length of the mass-culture phase. In contrast only 44% of the 
autaptic iNs generated at DPI 35 exhibited spontaneous and 32% showed evoked NT release. In the autaptic iNs 
generated at DPI 14 this fraction was even less, with only 14.3% of the iNs having evoked postsynaptic responses. 
In the subsequent characterization we therefore exclusively considered human autaptic iNs replated at DPI 60 as 
80% of the resulting autaptic iNs showed spontaneous and evoked NT release after 14–21 days (Fig. 1B).
The properties of iPSC lines generated by different methodologies can vary extensively25. For the following 
experiments we therefore generated autaptic hiNs from two independent iPSC lines available from the Berlin 
Institute of Health Core Facility Stem Cells (Berlin, Germany) to ensure that our protocol is generally applicable 
to iPSCs: the male iPSC line BIHi001-A derived from human foreskin fibroblasts using Sendai virus vectors and 
the female iPSC line BIHi004-A derived from normal human fibroblasts using episomal vectors.
Morphology of hiNs in autaptic cultures. Using immunocytochemistry, we analysed morphological 
features of the DPI 60 + 14 autaptic iNs. They possessed the general features of differentiated neurons in cul-
ture, namely a compact cell soma, MAP2-positive dendritic trees and extensive neurofilament-positive axons. 
Quantitative analysis of MAP2-positive neurites showed that dendritic trees were rather short, with mean lengths 
of 377 ± 83 µm and 253 ± 35 µm in BIHi001- and BIHi004-derived iNs, respectively (Fig. 1C), and axonal out-
growth, exemplified by SMI312 labelling, was longer, reaching 4.5 ± 0.6 mm and 3.0 ± 0.3 mm in BIHi001- and 
BIHi004-derived iNs, respectively, than murine hippocampal neurons (Fig. 1C)12,26.
We quantified synapse formation by counting synaptophysin-positive punctae colocalising with 
MAP2-positive dendrites (Fig. 1D). Synapse densities were 26 ± 3 and 42 ± 3 per 100 µm in BIHi001 and 
BIHi004 iNs resulting in a total synapse number of 98 and 106 synapses per cell, respectively.
Ion channel characteristics. We used whole-cell patch-clamp recordings in order to examine the passive 
and active membrane properties of the autaptic human iNs (Fig. 2) to validate their maturity. Neurons derived 
from BIHi001- or BIHi004-iPSCs had a similar mean resting membrane potential of −55 mV, input resist-
ance of approximately 375 MΩ and membrane capacitance around 30 pF (Fig. 2A). All autaptic iNs possessed 
voltage-dependent sodium and potassium currents (Fig. 2B, also see Fig. 3A). Current-clamp experiments also 
demonstrated robust action potential firing as a function of injected current (Fig. 2C).
We quantified excitatory and inhibitory NT receptor expression in the hiNs by exogenous application of 
the respective agonists (Fig. 2D). Application of kainic acid (20 µM) elicited a mean current density of approx-
imately 10 pA/pF (Fig. 2D, left), indicating AMPA-type glutamate receptor expression. In contrast, application 
of NMDA (100 µM) yielded negligible currents, indicating poor expression of NMDA receptors (Fig. 2D, mid-
dle). Application of GABA (5 µM) led to robust responses in all iNs tested (Fig. 2D, right). These results indicate 
expression of GABA receptors in iNs from both iPSC lines (BIHi001-, 92.9 ± 12.6 pA/pF and BIHi004-derived 
hiNs, 67.02 ± 12.37 pA/pF).
Neurotransmission in autaptic hiNs. Upon AP induction, a large majority of the cells (85%) responded 
with a synaptic inward current, demonstrating the high efficiency of our protocol for generating functional, 
mature, autaptic hiNs (Fig. 3A). We did notice that the time between induction of APs and postsynaptic responses 
was more variable compared to murine autaptic cultures11, which we attributed to more extensive axonal out-
growth in the hiNs (Fig. 1C). The postsynaptic responses were quantitatively blocked by saturating concentration 
of the AMPA receptor antagonist NBQX, confirming a glutamatergic phenotype (Fig. 3B). The responses were 
robust with mean amplitudes of 1.1 ± 0.2 nA and 1.0 ± 0.1 nA in BIHi001- and BIHi004-derived hiNs, respec-
tively (Fig. 3B,C).
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One of the major advantages of the autaptic culture system is that it allows for quantification of the 
readily-releasable pool (RRP) of vesicles, which is a product of the number of fusion-competent vesicles per 
synapse and the number of synapses. The RRP is determined by application of hypertonic sucrose solution 
onto the neurons using a fast-flow perfusion system27. This results in a transient inward current, which can be 
quantified by integration (Fig. 3D). The mean RRP charges were 50 ± 10 pC and 67 ± 11 pC in BIHi001- and 
BIHi004-derived hiNs, respectively (Fig. 3D).
In the absence of stimulation, we recorded spontaneous NT release indicated by miniature excitatory postsyn-
aptic currents (mEPSCs) (Fig. 3G). The mean mEPSC amplitude was significantly smaller in BIHi004- compared 
to BIHi001-derived hiNs (Fig. 3H) (BIHi001-: 39.7 ± 2.4 pA; BIHi004-derived hiNs: 30.4 ± 2.8 pA; p = 0.0024), 
but spontaneous release frequencies were around 2 Hz for both hiN lines (Fig. 3G). We next quantified the 
mEPSC charge and divided it by the RRP charge to compute the total number of SVs in the RRP. BIHi001-derived 
hiNs had an average of 618 ± 97 vesicles (Fig. 3E), which results in an average of 6.2 fusion-competent vesicles 
per synapse. BIHi004-derived iNs had an average of 869 ± 113 vesicles, which equals 8.2 fusion-competent SVs 
per synapse.
Knowing the RRP and the EPSC charges we determined the fusion efficiency of individual fusion-competent 
vesicles by calculating the vesicular release probability (PVR). PVR is the likelihood that a given fusion competent 
SV is released in response to an AP. We found that the PVR was 14.2 ± 2.3% and 11.1 ± 2.1% in BIHi001- and 
BIHi004-derived iNs, respectively (Fig. 3F).
We also calculated the spontaneous release rates of individual fusion-competent vesicles by normalizing 
mEPSC frequency (Fig. 3G) to RRP size (Fig. 3E). HiNs had a high spontaneous release rate, where 0.8 ± 0.1% 
Figure 1. Human neurons in autaptic culture. (A) Schematic diagram of the autaptic culture protocol for hiNs. 
IPSCs were plated and infected with Ngn2, rtTA and eGFP on day −1, followed by application of doxycycline to 
start Ngn2 expression and puromycin selection on day 0 to 3. HiNs were co-cultured with mouse astrocytes for 
60 days, followed by dissociation with Accutase and replating onto astrocytic microislands. Single autaptic iNs 
were analysed after 14–21 days. (B) Quantification of electrophysiological recordings of autaptic iNs replated 
on microislands after 14, 35 or 60 days post induction (DPI) in the mass-culture phase, followed by another 
14–21 days of cultivation on microislands. (C) Representative images and quantification of total axonal and 
dendritic lengths of human autaptic iNs. Dendrites were identified by MAP-2 staining and axonal processes 
were stained with SMI-312. Images in each row belong to the same iN lines. Scale bars: 50 µm. (D) Example 
images and quantification of synapse density in human autaptic iNs. Synapses were identified by Synaptophysin 
labelling. Only synaptophysin punctae (red) on top of MAP-2 staining (blue) were counted. Scale bars: 5 µm. 
The numbers of neurons and independent cultures analysed are shown within the bars. Data are expressed as 
mean ± SEM.
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Figure 2. Passive membrane properties and ion channel characteristics of iNs in autaptic culture. (A) Average 
resting membrane potential, input resistance and membrane capacitance of autaptic iNs. (B) Representative 
traces (left) and quantitative analysis of whole-cell voltage-clamp Na+/Ca2+ and K+-currents (right). (C) 
Representative traces (left) and quantitative analysis of the number of APs per second elicited by current 
injections in current-clamp recordings (right). (D) Quantification of whole-cell currents evoked by application 
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and 0.5 ± 0.2% of the RRP is turned over within a second in BIHi001- and BIHi004–derived hiNs, respectively 
(Fig. 3I).
The relatively high release probability and high spontaneous release rates in the hiNs suggest high vesicle 
fusogenicity13. This hypothesis was supported by the relatively strong depression of the EPSCs in response to a 
paired-pulse stimulus (Fig. 3J) as well as 10 Hz train stimulation (Fig. 3K) observed in both hiN lines.
Postsynaptic responses are mediated by AMPA receptors in autaptic hiNs. We utilized specific 
antagonists for AMPA (NBQX; 3 µM) and NMDA receptors (D-AP5; 10 µM) at saturating concentrations in order 
to examine the glutamatergic receptor composition at the hiN postsynapse. The results differed between hiN 
lines, with BIHi001-derived iNs showing no evidence of NMDA receptor - mediated synaptic transmission, while 
in BIHi004-derived iNs the NMDA receptors contributed around 5% to the EPSC amplitude (Fig. 4A). These 
data indicate a general deficiency in NMDA receptor expression or surface location, consistent with our results 
obtained from exogenous application of AMPA and NMDA receptor agonists (Fig. 2D) and with gene expression 
analysis performed by others5.
Modulation of glutamate release by metabotropic receptors and phorbol esters. Release 
from human glutamatergic synapses is also modulated by well-known modifiers of release probability. First, the 
GABAB agonist Baclofen (20 µM), which inhibits release from glutamatergic synapses28, rapidly and reversibly 
reduced EPSC amplitudes by 69% and 77% in BIHi001- and BIHi004- derived iNs, respectively (Fig. 4B). These 
results demonstrate that the human glutamatergic iNs generated by forced expression of Ngn2 express presynap-
tic GABAB receptors and efficiently couple them to the release apparatus.
Second, release is also modulated by metabotropic glutamate receptors (mGluRs). 1 µM DCG-IV, the agonist 
for type II mGluRs, inhibited synaptic transmission significantly in both iN lines (9.2% in BIHi001-derived iNs; 
7.4% in BIHi004-derived iNs; Fig. 4C). In contrast, only BIHi004-derived iNs responded to activation of type III 
mGluRs by the agonist L-AP4 (30 µM) with a small but significant reduction of EPSC amplitudes by 12% (Fig. 4D).
Finally, synaptic responses are potentiated by phorbol esters, which are known to modulate vesicle fusogenic-
ity through activation of the Unc13 proteins13,21. Application of 1 µM of PDBu rapidly increased the evoked 
responses, plateauing at 123% and 142% in BIHi001- and BIHi004-derived iNs, respectively (Fig. 4E). The overall 
degree of potentiation was modest, consistent with the high initial release probability13,29 (Fig. 3).
Knockdown of Unc13A abolishes evoked and spontaneous NT release. We developed the autaptic 
hiN protocol also to study human synaptic protein function in the human cellular background. To test whether it 
is sufficient to genetically modify the hiNs during replating, we developed a shRNA-based knockdown (KD) assay 
for Unc13A, a homologue of the murine priming factor Munc13-1. Expression of Unc13A-specific shRNA in iNs 
by means of lentiviral infection led to a nearly complete reduction of Unc13A protein level when tested in the 
mass-culture (Fig. 5A) and to a complete loss of evoked NT release in autaptic hiN cultures (Fig. 5B). Application 
of hypertonic sucrose solution showed that there was no measurable RRP in these hiNs (Fig. 5C). These results 
are consistent with an indispensable role of Unc13A in the priming of SVs, as it has been observed in murine 
loss-of-function models23.
Discussion
Here, we established the first two-phase protocol for the autaptic culture of human iPSC-derived neurons. Using two 
independent iPSC lines we demonstrate that our method reliably and reproducibly generates mature hiNs growing 
in isolation on astrocytic microislands and forming functional synapses onto themselves. Additionally, we success-
fully modified gene expression in the autaptic hiN leading to major changes in the observed synaptic properties.
To establish autaptic cultures of hiNs we had to overcome two major difficulties: the limited life time of the 
astrocytic microislands24, and the fact that hiNs have a low survival rate when grown in isolation early on during 
their differentiation process. To circumvent both obstacles, we split the culturing protocol into two phases: in the 
first phase the hiNs were allowed to mature in a mass culture setting, after which they were replated onto astro-
cytic microislands for a second “autaptic” culturing phase. Timeline experiments indicated that the iNs indeed 
needed 60 days of cell-to-cell contact to properly mature. This time is not necessary to build synapses for func-
tional autaptic connections as during replating the iNs lose the majority of their neurites and subsequently reform 
synapses during the two-weeks autaptic phase.
Overall, the autaptic iNs had passive membrane properties comparable to primary murine cultured neurons30 
and mass cultured hiNs derived from embryonic stem cells3,5,8–10,31. While the overall cellular morphology also 
appeared mature, dendrites were relatively short when compared to primary mouse autaptic neurons12,26. We 
think this is not specific for hiNs but rather caused by the replating or culturing procedure because estimates 
for mass-cultured iN dendrites are longer3,9,10. In contrast, the axonal outgrowth appears much more resilient 
to replating, as axon lengths were comparable to estimates from mass-cultured hiNs10 and were 50–250% longer 
than those of primary mouse hippocampal neurons in autaptic culture12. The synapse densities were comparable 
to those of autaptic rodent neurons12,26, but because of the shortened dendritic lengths, the total synapse numbers 
were reduced accordingly.
of either 20 µM kainic acid (left), 100 µM NMDA (middle) or 5 µM GABA (right) in the presence of 10 µM 
glycine and in the absence of Mg2+. The numbers of neurons and independent cultures analysed are shown 
within the bars. Data are expressed as mean ± SEM.
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The functional properties of the autaptic iNs were overall consistent with the mass-cultured iNs described by 
Zhang and colleagues, which also showed a lack of NMDA receptor expression5. However, the synaptic responses 
we recorded were much larger than those measured in mass culture5,8,9,31. Depending on the presynaptic stimu-
lation technique (e.g. paired recordings, field stimulation) the responses in mass culture only reflect a small and 
highly variable fraction of the synaptic input onto the recorded postsynaptic neuron. In contrast, the autaptic 
culture system has the unique advantage that inputs are monosynaptic and originate all from the same neuron. 
Therefore, it allows for quantitative assessment of the total synaptic input and output of a given neuron with a 
single AP stimulation.
The combined functional and morphological analysis in the autaptic hiNs allowed us to describe in more 
detail the properties of individual human synapses. For example, we noticed that the number of readily-releasable 
SVs per synapse was in the range of 5 to 10 vesicles, a value similar to that reported in rodent hippocampal neu-
rons32,33. Computation of release probability and spontaneous release rates indicated that hiN vesicles display 
rather high fusogenicity, reminiscent of high release probability glutamatergic neurons, such as layer 4 cortical 
neurons34. The mechanism for the rather high fusogenicity is unknown but may be related to the expression of 
the vesicular glutamate transporter subtype 25, which is known to be associated with intrinsically higher release 
probability35. High vesicle fusogenicity is also consistent with the moderate potentiation by PDBu application13,29.
Modulation of NT release by activation of presynaptic metabotropic receptors and their associated second 
messenger systems plays an important role for proper neuronal and brain function36. Metabotropic receptors 
are targets in the drug development and treatment of several neuropsychiatric disorders37–39. The identification 
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Figure 3. AP-evoked and spontaneous NT release and vesicular release probability of autaptic iNs. (A) Fraction 
of neurons which showed membrane voltage-dependent K+ and Na+/Ca2+ currents, EPSC and mEPSC in 
autaptic hiN cells. (B) Representative traces of AP-evoked EPSCs recorded in the absence or presence of the 
AMPA receptor antagonist NBQX. (C) Mean AP-evoked EPSC amplitudes of iNs induced from BIHi001- and 
BIHi004-iPSCs. (D) Exemplary trace of the synaptic response of an autaptic iN elicited by 500 mM hypertonic 
sucrose solution (left) and average size of the RRP charges (right). (E,F) Number of SVs in the RRP (E) and 
mean PVR (F). (G) Exemplary mEPSCs recorded from autaptic iNs in the absence or presence of NBQX (left) 
and mean mEPSC frequencies in BIHi001- and BIHi004-derived iNs (right). (H) Mean amplitudes and charges 
of mEPSCs. (I) Spontaneous release rate of human autaptic iNs. (J) Average paired-pulse ratios (PPR) calculated 
from two EPSCs with an ISI of 25 ms. (K) Normalized EPSC amplitudes during a 10 Hz train stimulation. AP 
artefacts were blanked and are indicated by black arrows. The numbers of neurons and independent cultures 
analysed are shown within the bars. Data are expressed as mean ± SEM.


















































































































Figure 4. Modulation of glutamate release by metabotropic receptors and phorbol esters. (A) Components of 
the EPSCs mediated by AMPA and NMDA receptors. (B–D) Comparison of EPSC amplitudes with and without 
Baclofen (B), L-AP4 (C) and DCG-IV (D). (E) EPSC potentiation by application of PDBu. AP artefacts were 
blanked and are indicated by black arrows. The numbers of neurons and independent cultures analysed are 
shown within the bars. Data are expressed as mean ± SEM.
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time, assessment of the modulation of NT release by second messenger systems requires reliable quantification 
of evoked synaptic responses, which is the major advantage of the autaptic cell culture system. Using our autaptic 
culture system for hiNs, we showed that synaptic transmission of these neurons is reliably modulated by GABAB 
and metabotropic glutamate receptors.
While our analyses identified variations in some of the morphological and functional properties of the two 
iN lines, the overall differences were rather small, emphasizing the robustness and stability of our system. Those 
differences we encountered may have arisen from genetic and epigenetic variations within the iPSC lines40.
We demonstrated that using shRNA-based KD assays during replating is sufficient to generate loss-of-function 
models for synaptic proteins. The KD of Unc13A recapitulated the complete disruption of synaptic NT release in 
Munc13-1/2 DKO neurons23. Hence, the here described two-phase protocol for autaptic iNs is especially flexible 
for protein structure-function experiments and modelling of human diseases, because it is sufficient to keep one 
or two lines of wildtype iNs during the mass-culture phase, which can then be used to study different protein 
functions during the autaptic culturing phase.
Our autaptic culture technique constitutes a versatile platform for multilevel phenotypic analyses of 
hiNs. With the here described technique, alterations in important synaptic parameters, such as the number of 
fusion-competent vesicles and their individual release probability, can now be more comprehensibly analysed and 
compared in a much more quantitative manner than with mass culture techniques. In conjunction with in situ 
genome editing, it will allow the identification and analyses of developmental, morphological and/or functional 
aspects of proteins of interest. The electrophysiological, pharmacological and immunocytochemical analyses of 
neuronal morphology and function shown here can be extended to a two-neuron microcircuit system to study the 
interaction of different cell types or mutant and wildtype cells12,26,41,42. The autaptic culture system also represents 
a powerful tool to distinguish between cell-autonomous and non-cell-autonomous regulatory processes12,26 and to 
describe the cellular phenotypes associated with neurological disorders such as Rett syndrome12,43,44, and neuro-
degenerative diseases, such as Alzheimer’s Disease45,46. In addition the autaptic cell culture technique can also be 
combined with other common methods, such as calcium indicators and vesicle pH dynamics imaging47 or electron 
microscopy that would allow for further analyses of calcium signalling and the SV cycle. Additionally, combining 
the electrophysiological functional analysis with single cell RNA sequencing in a Patch-Seq approach25,48 will aid in 
identifying molecular signalling pathways underlying a particular cellular phenotype.
Experimental Procedures
Ethical statement. All animals used were handled in accordance with the relevant guidelines and regu-
lations. Protocols were approved by the ‘Landesamt für Gesundheit und Soziales’ (LaGeSo; Regional Office for 
Health and Social Affairs) in Berlin and animals reported under the permit number T0220/09.
Virus Generation. Lentiviruses were produced by cotransfection of HEK293T cells with 10 µg envelope/
packaging plasmids (3,9 µg pRSV-REV (Addgene Plasmid #12253), 8,1 µg pMDLg/pRRE (Addgene Plasmid 
#12251), 6 µg VSVg (Addgene Plasmid #12259)) and 12 µg cDNA transfer plasmids per 75 cm2 culture area using 
PEI MAX (Polyscience) transfection49. Supernatants containing lentiviruses were harvested 48 hr after transfec-
tion and purified using Amicon Ultra-15 Centrifugal Filter units Ultracel-100 K (Merck Millipore). Only virus 
batches with >90% infection efficiency, as assessed by fluorescent reporter expression or puromycin resistance, 
were used for experiments. cDNA constructs for rtTA (FUW-rtTA), Ngn2 (FUW-TetO-Ngn2-T2A-Puro) and 
eGFP (FUW-eGFP) expression were kindly provided by Prof. Thomas C. Südhof. For Unc13A KD a synthetic 
shRNA oligonucleotides (sequence: 5′ ggacaccatcaagcaatat ttcaagaga atattgcttgatggtgtcc ttttttccaa 3′) was inserted 

























































Figure 5. Loss of function by knockdown of Unc13A in BIHi001. (A) Immunoblot of Unc13A protein levels 
of iNs transduced with a shRNA against Unc13A or a control construct. Signal at 200 kDa corresponds to 
the expected Unc13A, and the signal at 50 kDa to β-Tubulin. Western blot images have been cropped for 
presentation. Full size image are presented in Supplementary Fig. S1. (B) Exemplary traces of AP-evoked EPSCs 
(left) and average EPSC amplitudes (right). (C) Exemplary traces of the currents evoked by 500 mM hypertonic 
sucrose solution (left) and average sizes of the RRP charges (right) in KD and control (CTL) conditions. (ND, 
not detectable). AP artefacts were blanked and are indicated by black arrows. The numbers of neurons and 
independent cultures analysed are shown within the bars. Data are expressed as mean ± SEM.
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Generation of hiN Cells from human iPSCs. IPSCs were obtained from two independent iPSC lines pro-
vided by the Berlin Institute of Health Core Facility Stem Cells (Germany): The BIHi001-A (https://hpscreg.eu/
cell-line/BIHi001-A) and BIHi004-A (https://hpscreg.eu/cell-line/BIHi004-A) iPSC lines. IPSCs were maintained 
as feeder-free cells in Essential 8 flex medium (ThermoFisher Scientific) in a standard incubator (37 °C, 5% CO2).
Excitatory hiNs were produced as described previously5. In brief, iPSCs were dissociated with Accutase cell 
dissociation reagent (ThermoFisher Scientific), plated on Matrigel (Corning) - coated 6-well plates (1,7 × 105 
cells/cm2) in Essential 8 flex medium supplemented with 2 µM thiazovivin (Tocris) and infected with lentivi-
ral vectors on day −1. On day 0, the medium was changed to DMEM/F12 (ThermoFisher Scientific) contain-
ing N-2 supplement (ThermoFisher Scientific), non-essential amino acids (ThermoFisher Scientific), human 
BDNF (10 mg/l, PeproTech), human NT-3 (10 mg/l, PeproTech), mouse laminin (0.2 mg/l, ThermoFisher 
Scientific) and doxycycline (2 µg/ml, Sigma Aldrich) to induce TetO-dependent gene expression. Doxycycline 
was retained in the medium until the end of the experiments. On day 2 and 3 DMEM/F12 medium was 
replaced and 0.5 mg/l puromycin was included to select only induced iNs. On day 4 medium was changed to 
Neurobasal-A medium (ThermoFisher Scientific) containing B-27 supplement (ThermoFisher Scientific), 
GlutaMAX (ThermoFisher Scientific) human BDNF (10 mg/l), human NT-3 (10 mg/l), mouse laminin (0.2 mg/l), 
Cytosine β-D-arabinofuranoside (Ara-C) (2 mg/ml, Sigma Aldrich) and doxycycline (2 µg/ml) and mouse glial 
cells were included (3 × 105 cells/cm2). From day 7 on half of the medium in each well was replaced every 5 
days with Neurobasal-A medium containing B-27 supplement, GlutaMAX, doxycycline (2 µg/ml) and 2.5% fetal 
bovine serum (PanBiotech). After 50–70 days, cells were washed twice with 0.5 mM EDTA/PBS (ThermoFisher 
Scientific) and dissociated with Accutase (2 x for 7 min at 37 °C). GFP-positive cells were seeded in a density 
of 3.3 × 103 cells/cm2 onto astrocyte microislands to obtain autaptic cultures. Astrocytic islands were produced 
from mouse cortical glial cells derived from newborn C57/Bl6 mice. Microislands of growth-permissive substrate 
(collagen I (ThermoFisher Scientific), and poly-D-lysine (Sigma Aldrich, St. Louis, MO, USA)) were printed onto 
30 mm round coverslips precoated with agarose type 4 (ThermoFisher Scientific). Astrocytes were plated at a den-
sity of 5 × 103 cells per cm2 onto the microdot-coated coverslips one week before iNs were added. These cultures 
were maintained for another 13–21 days in a humidified incubator (37 °C and 5% CO2).
Immunocytochemistry. Cells were fixed between day 80 and 121 in prewarmed 4% paraformaldehyde (PFA, 
Sigma Aldrich)/4% sucrose (Sigma Aldrich) in PBS (Merck Millipore) for 10 min at room temperature (RT). Cells 
were permeabilized for 15 min in PBS/0.1% Tween-20 (Carl-Roth GmbH + Co. KG), incubated in quenching solu-
tion (100 mM glycine in PBS) for 30 min and blocked in 5% normal donkey serum (Jackson ImmunoResearch Inc.) 
for 1 hour at RT. Cells were incubated with primary antibodies over night at 4 °C. The following primary antibod-
ies were used: chicken anti-microtubule-associated protein 2 (MAP2) (1:2000; Merck Millipore, AB5543), mouse 
anti-pan-axonal neurofilaments (SMI-312; 1:1000; Covance Inc.); mouse anti-synaptophysin (1:200; Synaptic 
Systems). After washing the cells 3 x with PBS-T, primary antibodies were labelled with secondary antibodies 
Alexa-Fluor 405 or 647 (1:500; Jackson ImmunoResearch Inc.) for 1 hr at RT. Cells were washed 2 x in PBS-T and 
once in PBS and mounted on glass slides with Mowiol (ThermoFisher Scientific).
Western blot. For quantification of Unc13A protein levels, hiN cells were lysed 14 days post transduction 
at 4 °C with lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.2% NP-40, protease inhibitor cocktail complete 
mini (Roche Diagnostics)). Equal amounts of total protein from the lysates of Unc13A-KD or scrambled con-
trol virus were separated on SDS polyacrylamide gel and transferred to a nitrocellulose membrane. Membranes 
were blocked for 1 hour with 5% skim milk in PBS-T and incubated at 4 °C over night with primary antibodies: 
anti-Munc 13-1 (126103 Synaptic Systems) and anti- β-Tubulin III (T8660 Sigma-Aldrich). Secondary antibodies 
were horseradish peroxidase-conjugated (Jackson ImmunoResearch). Detection was performed by using ECL 
Plus Western Blotting Detection Reagents (GE Healthcare Biosciences) in a Fusion FX7 detection system (Vilber 
Lourmat). Data were analysed offline using ImageJ.
Morphological analysis. For morphological analysis, stacks of 16-bit fluorescence images were acquired 
on an Olympus IX81 inverted microscope equipped with a 10X or 20X objective (neurite length analysis) or a 
60X water immersion objective (synaptic density analysis). Images were acquired with a CCD camera (Princeton 
MicroMax; Roper Scientific) using MetaMorph software (Molecular Devices). All images were analysed using 
ImageJ software (National Institutes of Health). For each image stack maximum intensity projection were 
generated. Uniform background subtraction and optimal threshold adjustment was performed on all images. 
Quantification of MAP2-positive or neurofilament (SMI312)-positive processes with the NeuronJ plugin was 
used to determine total dendritic and axonal lengths. The density of synaptophysin-positive punctae overlapping 
with MAP2-positive dendrites was determined using a custom-written ImageJ plugin. Two independent cultures 
were imaged and analysed per group for every experiment.
Electrophysiology. Whole-cell patch-clamp recordings were performed between day 63 and 91 post neu-
ronal induction at RT using a Multiclamp 700B amplifier (Molecular Devices). The series resistance was compen-
sated by 70% and only cells with series resistances of <12 MΩ were analysed. Data were acquired at 10 kHz using 
pClamp 10 software (Molecular Devices) and filtered using a low-pass Bessel filter at 3 kHz. Data were analysed 
offline using Axograph X (Axograph Scientific). The patch pipette solution contained 136 mM KCl, 17.8 mM 
HEPES, 1 mM EGTA, 0.6 mM MgCl2, 4 mM ATP-Mg, 0.3 mM GTP-Na, 12 mM phosphocreatine, and 50 units/
mL phosphocreatine kinase (300 mOsm, pH 7.4, all Carl-Roth). The recording chamber was constantly perfused 
with extracellular solution containing 140 mM NaCl, 2.4 mM KCl, 10 mM HEPES, 2 mM CaCl2, 4 mM MgCl2, 
and 10 mM glucose (pH adjusted to 7.3 with NaOH, 300 mOsm, all Carl-Roth). For experiments examining 
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postsynaptic receptors Figs 2D and 4A we used a Mg2+-free extracellular solution containing 10 µM glycine. 
Solutions were applied using a fast-flow perfusion system.
For whole-cell voltage clamp recordings, neurons were maintained at −70 mV holding potential. Cells were 
subjected to 500 ms depolarizations in 10 mV steps from −90 mV to +50 mV to analyse Na+/Ca2+ and K+ currents.
AP firing patterns and passive membrane properties were recorded in whole-cell current-clamp configuration. 
Bridge balance was automatically compensated. 300 ms current steps from −40 pA to 120 pA were injected. The 
resting membrane potentials were analysed from baseline and the input resistances were calculated by Ohms law 
using a current step of −50 pA for 600 ms.
Membrane standing glutamatergic and GABAergic ionotropic receptor function was tested by pulsed appli-
cation (1 s) of 20 µM kainic acid, 100 µM N-Methyl-D-aspartic acid (NMDA) and 5 µM γ-Aminobutyric acid 
(GABA) (all Tocris). Peak amplitudes from six consecutive sweeps were averaged. The values were normalized to 
the cell capacitance.
EPSCs were evoked by 2 ms somatic depolarization from −70 to 0 mV producing an unclamped axonal AP. 
To determine the size of the RRP, 500 mM sucrose (Sigma Aldrich) solution was applied for 5 s and the resulting 
transient inward current was integrated27. mEPSC were detected using a sliding template function in AxoGraph 
X51 and false positive events were corrected by using the selective competitive receptor antagonist 2,3-Dioxo-
6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; 3 µM (Tocris)). The number of vesicles 
in the RRP was calculated by dividing the charge of the sucrose response by the average mEPSC charge for each 
neuron. The PVR was calculated as the ratio of the average EPSC charge and the RRP charge. The spontaneous 
release rate was determined by dividing the mEPSC frequency by the number of vesicles in the RRP for each cell. 
The paired-pulse ratio (PPR) was calculated by applying two stimuli with an inter-stimulus interval (ISI) of 25 ms 
and dividing the amplitude of the second EPSC by that of the first EPSC.
For pharmacological studies with 30 µM L-(+)-2-Amino-4-phosphonobutyric acid (L-AP4) (Tocris), 20 µM 
R-Baclofen (Tocris), 10 µM D-(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) (Tocris), 3 µM NBQX (Tocris) 
and 1 µM (2S,2′R,3′R)-2-(2′,3′-Dicarboxycyclopropyl) glycine (DCG IV) (Tocris) baseline EPSC amplitudes were 
monitored at 0.2 Hz for 30 s without drug application, followed by 30 s in the presence of the drug and another 30 s 
without drug application. The degree of EPSC depression or potentiation was determined by dividing the mean 
EPSC amplitude in the presence of the drug by the mean EPSC amplitude before drug application in extracellular 
solution of the same cell. The degree of EPSC potentiation of 1 µM phorbol-12,13-dibutyrate (PDBu) (Tocris) 
was determined by monitoring EPSC amplitudes at 0.2 Hz for 15 s in standard extracellular solution followed by 
30 s with drug application. The degree of potentiation was calculated by normalizing to the first EPSC amplitudes 
recorded in standard extracellular solution.
Statistics. Data were collected from 2–9 independent hiN autaptic cultures (replicates N) to account for 
putative culture to culture variability. For each replicate, hiNs were generated by an individual induction process 
from each human iPSC line and these hiNs were then used only for one autaptic culture. For electrophysiological 
experiments, we obtained an equal number of recordings in the range of 5 to 15 cells per experimental group in 
each replicate culture. For details see Supplementary Table S1.
Statistical significance was determined by using the two-tailed Mann Whitney test for unpaired data at the 
given significance level (*p < 0.05, **p < 0.01, ***p < 0.001) using GraphPad Prism 7.
Data Availability
Data generated and analysed in this study are available from the corresponding author upon request.
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